Abstract:【Objective】 To describe the clinical characteristics and outcomes of patients with adulthood-onset moyamoya disease (A-MMD) and compare the correlations between non-genetic factors and the clinical outcome. 【Methods】 The clinical data of 109 consecutive adult moyamoya patients in our hospital were retrospectively analyzed. These patients were divided into cerebral hemorrhage group and cerebral ischemia group based on the results of CT and were conservatively followed up. 【Results】 The most common cortical clinical manifestation was headache (38.5%, 42/109) and most of the hemispheres were in Suzuki and Takaku angiographic stage Ⅲ (65.1%). There was a higher percentage of hemorrhage (67.0%) than ischemia (33.0%), and 38 patients (34.9%) had multiple lesions on CT or MRI. There were 34 patients (46.6%) presented with repeated episodes of cerebral hemorrhage in the 73 patients with hemorrhage. There were positive correlations between brain hemorrhage (at the first episode) and death toll, aneurysm, recurrent event type (hemorrhage) and high triglyceride (P < 0.05). The features of CT/MRI at the first diagnosis (hemorrhage), number of recurrent stroke events, hypertension and recurrent event type (hemorrhage) were significantly associated with the risk of death (P < 0.05). The overall survival in 2, 4, 6, 8 and 10 years were 98.1%, 89.4%, 79.1%, 77.8% and 66.6% respectively. 【Conclusions】 A-MMD patients have high percentages of hemorrhage and headache. High triglyceride and hypertension may play some roles in the development of A-MMD, especially in patients with cerebral hemorrhage.